Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer
Clinical trial NCT05364489 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05364489
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2025-06-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.